Nova Eye Medical Stock EBITDA
| EYE Stock | 0.13 0.01 7.14% |
Nova Eye Medical fundamentals help investors to digest information that contributes to Nova Eye's financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Eye's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Eye stock.
Nova |
Nova Eye Medical Company EBITDA Analysis
Nova Eye's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Nova Eye EBITDA | (5.98 M) |
Most of Nova Eye's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Eye Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Nova Eye Medical reported earnings before interest,tax, depreciation and amortization of (5.98 Million). This is 100.68% lower than that of the Health Care Equipment & Supplies sector and 100.93% lower than that of the Health Care industry. The ebitda for all Australia stocks is 100.15% higher than that of the company.
Nova EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Eye's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nova Eye could also be used in its relative valuation, which is a method of valuing Nova Eye by comparing valuation metrics of similar companies.Nova Eye is currently under evaluation in ebitda category among its peers.
Nova Fundamentals
| Return On Equity | -0.39 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 31.42 M | ||||
| Shares Outstanding | 263.24 M | ||||
| Shares Owned By Insiders | 16.17 % | ||||
| Shares Owned By Institutions | 16.31 % | ||||
| Price To Book | 1.60 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 23.32 M | ||||
| Gross Profit | 20.19 M | ||||
| EBITDA | (5.98 M) | ||||
| Net Income | (8.79 M) | ||||
| Cash And Equivalents | 7.42 M | ||||
| Total Debt | 3.35 M | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (7.73 M) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 0.59 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 34.22 M | ||||
| Total Asset | 29.88 M | ||||
| Retained Earnings | (30.69 M) | ||||
| Working Capital | 9.07 M | ||||
| Net Asset | 29.88 M |
About Nova Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Eye Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Eye Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.